DexCom Inc.
Rating
Updated: Sep 1, 2026Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationa...
Latest News
6 days ago · businesswire.com
Dexcom Promotes Jereme Sylvain to Chief Operating OfficerSAN DIEGO--(BUSINESS WIRE)--Dexcom Promotes Jereme Sylvain to Chief Operating Officer.
6 days ago · zacks.com
Here's Why You Should Retain DexCom Stock in Your Portfolio for NowDXCM's strong growth, G7 15 Day adoption and CONNECT trial could expand its CGM market opportunity despite reimbursement and competition risks.
11 days ago · businesswire.com
Dexcom Appoints Glenn Boehnlein to Board of DirectorsSAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM), the global leader in glucose biosensing, today announced the appointment of Glenn Boehnlein to its Board of Directors, effective September 10, 2026. Mr. Boehnlein is a highly accomplished healthcare executive and finance leader with more than 20 years of experience in the medical technology industry. Most recently, he served as Vice President and Chief Financial Officer of Stryker Corporation, one of the world's leading medical technology.
12 days ago · seekingalpha.com
DexCom, Inc. (DXCM) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptDexCom, Inc. (DXCM) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
14 days ago · prnewswire.com
Did DexCom, Inc. Insiders Breach their Fiduciary Duties to Shareholders?Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
19 days ago · zacks.com
Why DexCom (DXCM) is a Top Growth Stock for the Long-TermWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
20 days ago · businesswire.com
Dexcom Announces Upcoming Conference PresentationSAN DIEGO--(BUSINESS WIRE)--DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the Wells Fargo 21st Annual Healthcare Conference on Wednesday, September 9, 2026. The live presentation is scheduled to begin at approximately 8:00 AM EDT and will be concurrently webcast. Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference. About DexCom, Inc. Dexcom em.
27 days ago · zacks.com
Abbott vs. DexCom: Which CGM Stock Is the Better Buy Now?ABT edges DXCM on price-target upside and valuation, while both pursue CGM growth through innovation, adoption and strong liquidity.
28 days ago · defenseworld.net
Great Lakes Advisors LLC Invests $369,000 in DexCom, Inc. $DXCMGreat Lakes Advisors LLC purchased a new position in shares of DexCom, Inc. (NASDAQ: DXCM) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 5,472 shares of the medical device company's stock, valued at approximately $369,000. Other hedge funds also recently added to
1 month ago · zacks.com
Here's Why DexCom (DXCM) is a Strong Momentum StockThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove DXCM